Postoperative intracerebral haematomas following stereotactic biopsies: Poor planning or poor execution?


Journal

The international journal of medical robotics + computer assisted surgery : MRCAS
ISSN: 1478-596X
Titre abrégé: Int J Med Robot
Pays: England
ID NLM: 101250764

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 03 08 2020
revised: 14 11 2020
accepted: 15 12 2020
pubmed: 22 12 2020
medline: 21 7 2021
entrez: 21 12 2020
Statut: ppublish

Résumé

Postoperative intracerebral haematomas represent a serious complication following stereotactic biopsy. We investigated the possible underlying causes - poor planning or poor execution - of postoperative intracerebral haematomas following stereotactic biopsies. We performed a technical investigation using a retrospective single-centre consecutive series of robot-assisted stereotactic biopsies for a supratentorial diffuse glioma in adults. Each actual biopsy trajectory was reviewed to search for a conflict with an anatomical structure at risk. From 379 patients, 12 (3.2%) presented with a postoperative intracerebral haematoma ≥20 mm on postoperative CT-scan (3 requiring surgical evacuation); 11 of them had available intraoperative imaging (bi-planar stereoscopic teleangiography x-rays at each biopsy site). The actual biopsy trajectory was similar to the planned biopsy trajectory in these 11 cases. In 72.7% (8/11) of these cases, the actual biopsy trajectory was found to contact a structure at risk (blood vessel and cerebral sulcus) and identified as the intracerebral haematoma origin. Robot-assisted stereotactic biopsy is an accurate procedure. Postoperative intracerebral haematomas mainly derive from human-related errors during trajectory planning.

Sections du résumé

BACKGROUND BACKGROUND
Postoperative intracerebral haematomas represent a serious complication following stereotactic biopsy. We investigated the possible underlying causes - poor planning or poor execution - of postoperative intracerebral haematomas following stereotactic biopsies.
METHODS METHODS
We performed a technical investigation using a retrospective single-centre consecutive series of robot-assisted stereotactic biopsies for a supratentorial diffuse glioma in adults. Each actual biopsy trajectory was reviewed to search for a conflict with an anatomical structure at risk.
RESULTS RESULTS
From 379 patients, 12 (3.2%) presented with a postoperative intracerebral haematoma ≥20 mm on postoperative CT-scan (3 requiring surgical evacuation); 11 of them had available intraoperative imaging (bi-planar stereoscopic teleangiography x-rays at each biopsy site). The actual biopsy trajectory was similar to the planned biopsy trajectory in these 11 cases. In 72.7% (8/11) of these cases, the actual biopsy trajectory was found to contact a structure at risk (blood vessel and cerebral sulcus) and identified as the intracerebral haematoma origin.
CONCLUSIONS CONCLUSIONS
Robot-assisted stereotactic biopsy is an accurate procedure. Postoperative intracerebral haematomas mainly derive from human-related errors during trajectory planning.

Identifiants

pubmed: 33345461
doi: 10.1002/rcs.2211
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2211

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Barnholtz-Sloan JS, Ostrom QT, Cote D. Epidemiology of brain tumours. Neurol Clin. 2018;36(3):395-419. https://doi.org/10.1016/j.ncl.2018.04.001.
GBD 2016 Brain and Other CNS Cancer Collaborators. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18(4):376-393. https://doi.org/10.1016/S1474-4422(18)30468-X.
Bush NAO, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017;40(1):1-14. https://doi.org/10.1007/s10143-016-0709-8.
Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998;82(9):1749-1755. https://doi.org/10.1002/(sici)1097-0142(19980501)82:9<1756::aid-cncr23>3.0.co;2-2.
Hamisch CA, Minartz J, Blau T, et al. Frame-based stereotactic biopsy of deep-seated and midline structures in 511 procedures: feasibility, risk profile, and diagnostic yield. Acta Neurochir (Wien). 2019;161(10):2065-2071. https://doi.org/10.1007/s00701-019-04020-1.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. Int Agency Res Cancer. 2007.
Muragaki Y, Chernov M, Maruyama T, et al. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate? Minim Invasive Neurosurg. 2008;51(5):275-279. https://doi.org/10.1055/s-0028-1082322.
Terrier L, Gilard V, Marguet F, Fontanilles M, Derrey S. Stereotactic brain biopsy: evaluation of robot-assisted procedure in 60 patients. Acta Neurochir (Wien). 2019;161(3):545-552. https://doi.org/10.1007/s00701-019-03808-5.
Yasin H, Hoff H-J, Blümcke I, Simon M. Experience with 102 frameless stereotactic biopsies using the neuromate robotic device. World Neurosurg. 2019;123:e450-e456. https://doi.org/10.1016/j.wneu.2018.11.187.
Li Z, Zhang J-G, Ye Y, Li X. Review on factors affecting targeting accuracy of deep brain stimulation electrode implantation between 2001 and 2015. Stereotact Funct Neurosurg. 2016;94(6):351-362. https://doi.org/10.1159/000449206.
Apuzzo ML, Chandrasoma PT, Cohen D, Zee CS, Zelman V. Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery. 1987;20(6):930-937. https://doi.org/10.1227/00006123-198706000-00019.
Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg. 1994;81(2):165-168. https://doi.org/10.3171/jns.1994.81.2.0165.
Kongkham PN, Knifed E, Tamber MS, Bernstein M. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci. 2008;35(1):79-84. https://doi.org/10.1017/s0317167100007605.
McGirt MJ, Woodworth GF, Coon AL, et al. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg. 2005;102(5):897-901. https://doi.org/10.3171/jns.2005.102.5.0897.
Mizobuchi Y, Nakajima K, Fujihara T, et al. The risk of haemorrhage in stereotactic biopsy for brain tumours. J Med Invest. 2019;66(3.4):314-318. https://doi.org/10.2152/jmi.66.314.
Zhang Q-J, Wang W, Wei X, Yu Y. Safety and efficacy of frameless stereotactic brain biopsy techniques. Chin Med Sci J. 2013;28(2):113-116. https://doi.org/10.1016/s1001-9294(13)60032-2.
Nishihara M, Sasayama T, Kudo H, Kohmura E. Morbidity of stereotactic biopsy for intracranial lesions. Kobe J Med Sci. 2011;56(4):E148-E153.
Grossman R, Sadetzki S, Spiegelmann R, Ram Z. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir (Wien). 2005;147(6):627-631. discussion 631. https://doi.org/10.1007/s00701-005-0495-5.
Chen J, Zhuo S, Luo T, Jiang X, Zhao J. Spectral characteristics of autofluorescence and second harmonic generation from ex vivo human skin induced by femtosecond laser and visible lasers. Scanning. 2006;28(6):319-326.
Chen C-C, Hsu P-W, Erich Wu T-W, et al. Stereotactic brain biopsy: single center retrospective analysis of complications. Clin Neurol Neurosurg. 2009;111(10):835-839. https://doi.org/10.1016/j.clineuro.2009.08.013.
Legnani FG, Franzini A, Mattei L, et al. Image-Guided biopsy of intracranial lesions with a small robotic device (iSYS1): a prospective, exploratory pilot study. Oper Neurosurg. 2019;17(4):403-412. https://doi.org/10.1093/ons/opy411.
Zanello M, Carron R, Peeters S, et al. Automated neurosurgical stereotactic planning for intraoperative use: a comprehensive review of the literature and perspectives. Neurosurg Rev. 2020. Published online May 20. https://doi.org/10.1007/s10143-020-01315-1.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. https://doi.org/10.1371/journal.pmed.0040296.
Pallud J, Varlet P, Devaux B, et al. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurol. 2010;74(21):1724-1731. https://doi.org/10.1212/WNL.0b013e3181e04264.
Daumas-Duport C, Monsaingeon V, Szenthe L, Szikla G. Serial stereotactic biopsies: a double histological code of gliomas according to malignancy and 3-D configuration, as an aid to therapeutic decision and assessment of results. Appl Neurophysiol. 1982;45(4-5):431-437. https://doi.org/10.1159/000101638.
Roux A, Roca P, Edjlali M, et al. MRI atlas of IDH Wild-type supratentorial glioblastoma: probabilistic maps of phenotype, management, and outcomes. Radiology. 2019;293(3):633-643. https://doi.org/10.1148/radiol.2019190491.
Marcus HJ, Vakharia VN, Ourselin S, Duncan J, Tisdall M, Aquilina K. Robot-assisted stereotactic brain biopsy: systematic review and bibliometric analysis. Child’s Nerv Syst. 2018;34(7):1299-1309. https://doi.org/10.1007/s00381-018-3821-y.
Lefranc M, Capel C, Pruvot-Occean A-S, et al. Frameless robotic stereotactic biopsies: a consecutive series of 100 cases. J Neurosurg. 2015;122(2):342-352. https://doi.org/10.3171/2014.9.JNS14107.
Malone H, Yang J, Hershman DL, Wright JD, Bruce JN, Neugut AI. Complications following stereotactic needle biopsy of intracranial tTumours. World Neurosurg 2015;84(4):1084-1089. https://doi.org/10.1016/j.wneu.2015.05.025.
Kulkarni AV, Guha A, Lozano A, Bernstein M. Incidence of silent haemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg. 1998;89(1):31-35. https://doi.org/10.3171/jns.1998.89.1.0031.
Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen H-J. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours - a prospective study. Acta Neurochir (Wien). 2001;143(6):539-546. https://doi.org/10.1007/s007010170058.
Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJJ, Vincent AJPE. Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien). 2008;150(1):23-29. https://doi.org/10.1007/s00701-007-1473-x.
Maciunas RJ, Galloway RL, Latimer JW. The application accuracy of stereotactic frames. Neurosurgery. 1994;35(4):682-694. discussion 694-695. https://doi.org/10.1227/00006123-199410000-00015.
von Langsdorff D, Paquis P, Fontaine D. In vivo measurement of the frame-based application accuracy of the neuromate neurosurgical robot. J Neurosurg. 2015;122(1):191-194. https://doi.org/10.3171/2014.9.JNS14256.
Khan MF, Mewes K, Gross RE, Skrinjar O. Assessment of brain shift related to deep brain stimulation surgery. Stereotact Funct Neurosurg. 2008;86(1):44-53. https://doi.org/10.1159/000108588.
Kulas Søborg M-L, Leganger J, Rosenberg J, Burcharth J. Increased need for gastrointestinal surgery and increased risk of surgery-related complications in patients with Ehlers-Danlos syndrome: a systematic review. Dig Surg. 2017;34(2):161-170. https://doi.org/10.1159/000449106.
Boström J, Yacoub A, Schramm J. Prospective collection and analysis of error data in a neurosurgical clinic. Clin Neurol Neurosurg. 2010;112(4):314-319. https://doi.org/10.1016/j.clineuro.2010.01.001.
Oremakinde AA, Bernstein M. A reduction in errors is associated with prospectively recording them. J Neurosurg. 2014;121(2):297-304. https://doi.org/10.3171/2014.5.JNS132341.
Englot DJ, Ouyang D, Wang DD, Rolston JD, Garcia PA, Chang EF. Relationship between hospital surgical volume, lobectomy rates, and adverse perioperative events at US epilepsy centers. J Neurosurg. 2013;118(1):169-174. https://doi.org/10.3171/2012.9.JNS12776.
Wang AY, Wang JT, Dexter M, Da Cruz M. The vestibular schwannoma surgery learning curve mapped by the cumulative summation test for learning curve. Otol Neurotol. 2013;34(8):1469-1475. https://doi.org/10.1097/MAO.0b013e31829bfc54.
Sato S, Dan M, Hata H, et al. Safe stereotactic biopsy for basal ganglia lesions: avoiding injury to the basal perforating arteries. Stereotact Funct Neurosurg. 2018;96(4):244-248. https://doi.org/10.1159/000492057.
Ellis T-M, Foote KD, Fernandez HH, et al. Reoperation for suboptimal outcomes after deep brain stimulation surgery. Neurosurgery. 2008;63(4):754-760. discussion 760-761. https://doi.org/10.1227/01.NEU.0000325492.58799.35.
Horn A, Li N, Dembek TA, et al. Lead-DBS v2: towards a comprehensive pipeline for deep brain stimulation imaging. NeuroImage. 2019;184:293-316. https://doi.org/10.1016/j.neuroimage.2018.08.068.
Medina Villalon S, Paz R, Roehri N, et al. EpiTools, A software suite for presurgical brain mapping in epilepsy: intracerebral EEG. J Neurosci Methods. 2018;303:7-15. https://doi.org/10.1016/j.jneumeth.2018.03.018.
Narizzano M, Arnulfo G, Ricci S, et al. SEEG assistant: a 3D Slicer extension to support epilepsy surgery. BMC Bioinf. 2017;18(1):124. https://doi.org/10.1186/s12859-017-1545-8.
Gerstle CR. Parallels in safety between aviation and healthcare. J Pediatr Surg. 2018;53(5):875-878. https://doi.org/10.1016/j.jpedsurg.2018.02.002.
Pallud J, Dezamis E. Functional and oncological outcomes following awake surgical resection using intraoperative cortico-subcortical functional mapping for supratentorial gliomas located in eloquent areas. Neurochirurgie. 2017;63(3):208-218. ISSN 0028-3770, https://doi.org/10.1016/j.neuchi.2016.08.003.
Marcus HJ, Vakharia VN, Sparks R, et al. Computer-assisted versus manual planning for stereotactic brain biopsy: a retrospective comparative pilot study. Oper Neurosurg Hagerstown Md. 2020;18(4):417-422. Published online August 5. https://doi.org/10.1093/ons/opz177.

Auteurs

Marc Zanello (M)

Service de Neurochirurgie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.

Alexandre Roux (A)

Service de Neurochirurgie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.

Clément Debacker (C)

Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.

Sophie Peeters (S)

Department of Neurosurgery, University of California, Los Angeles, California, USA.

Myriam Edjlali-Goujon (M)

Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Service de Neuroradiologie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.

Frédéric Dhermain (F)

Département d'Oncologie Radiothérapie, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.

Edouard Dezamis (E)

Service de Neurochirurgie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.

Catherine Oppenheim (C)

Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Service de Neuroradiologie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.

Emmanuèle Lechapt-Zalcman (E)

Université de Paris, Sorbonne Paris Cité, Paris, France.
Service de Neuropathologie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.

Marc Harislur (M)

Service de Neurochirurgie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.

Pascale Varlet (P)

Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.
Service de Neuropathologie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.

Fabrice Chretien (F)

Université de Paris, Sorbonne Paris Cité, Paris, France.
Service de Neuropathologie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.

Bertrand Devaux (B)

Service de Neurochirurgie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.

Johan Pallud (J)

Service de Neurochirurgie, GHU Paris - Psychiatrie et Neurosciences - Hôpital Sainte-Anne, Paris, France.
Université de Paris, Sorbonne Paris Cité, Paris, France.
Inserm, UMR1266, IMA-Brain, Institut de Psychiatrie et Neurosciences de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH